|
|
||||||||
Responses in Peripheral T Cells of G
i2/ Mice 1

,



* Wellman Center of Photomedicine, Massachusetts General Hospital, and Department of Dermatology, Harvard Medical School, Boston, MA 02114;
Synta Pharmaceuticals, Lexington, MA 02421;
Department of Pathology, Baylor College of Medicine, Houston, TX 77030; and
Department of Pathology, University of California, Irvine, CA 92697
Null mutation of heterotrimeric G protein
2 inhibitory subunit (G
i2) induces Th1-skewed hyperimmune responses in the colon, leading to chronic colitis and the development of colonic adenocarcinoma. However, the underlying molecular mechanisms and cellular basis, in particular, for the role of G
i2 in regulating immune responses, are poorly understood. We show here that peripheral T cells from G
i2-deficient mice do not respond normally to the inhibitory effects of TGF-
on proliferation and cytokine production, revealing a previously unappreciated cross-talk between these two signaling pathways. Lack of G
i2 resulted in decreased phosphorylation of Smad2 and Smad3 in T cells at the basal levels as well as at the late but not early phase of TGF-
stimulation, which appears to be ascribed to differential expression of neither cell surface TGF-
receptors nor Smad7. The altered phosphorylation of Smad proteins involves phospholipase C-mediated signaling, a downstream signaling molecule of G
i2, because phospholipase C inhibitors could restore Smad2 and Smad3 phosphorylation in G
i2/ T cells at levels comparable to that in wild-type T cells. Moreover, adoptive transfer of G
i2-deficient T cells into immunocompromised mice rendered an otherwise resistant mouse strain susceptible to trinitrobenzesulfonic acid-induced colitis, suggesting that an impaired response of G
i2-deficient T cells to TGF-
may be one of the primary defects accounting for the observed colonic Th1-skewed hyperimmune responses. These findings shed new lights on the molecular and cellular basis of how G
i2 down-regulates immune responses, contributing to the maintenance of mucosal tolerance.
This article has been cited by other articles:
![]() |
M. McPherson, B. Wei, O. Turovskaya, D. Fujiwara, S. Brewer, and J. Braun Colitis immunoregulation by CD8+ T cell requires T cell cytotoxicity and B cell peptide antigen presentation Am J Physiol Gastrointest Liver Physiol, September 1, 2008; 295(3): G485 - G492. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Hoang, A. Trinh, and R. A. Edwards Decreased MAPK- and PGE2-dependent IL-11 production in Gi{alpha}2-/- colonic myofibroblasts Am J Physiol Gastrointest Liver Physiol, June 1, 2007; 292(6): G1511 - G1519. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. D. Thompson, Y. Jin, K. H. Wu, R. A. Colvin, A. D. Luster, L. Birnbaumer, and M. X. Wu Inhibition of G{alpha}i2 Activation by G{alpha}i3 in CXCR3-mediated Signaling J. Biol. Chem., March 30, 2007; 282(13): 9547 - 9555. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Cassan, E. Piaggio, J. P. Zappulla, L. T. Mars, N. Couturier, F. Bucciarelli, S. Desbois, J. Bauer, D. Gonzalez-Dunia, and R. S. Liblau Pertussis Toxin Reduces the Number of Splenic Foxp3+ Regulatory T Cells J. Immunol., August 1, 2006; 177(3): 1552 - 1560. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |